SS-31 (50mg)

Key Features:

• SS-31 (50mg) is a mitochondrial-targeted peptide that effectively binds to the inner mitochondrial membrane, where it improves mitochondrial function, reduces reactive oxygen species (ROS), and enhances cellular energy production. This peptide is integral to studies in cardioprotection, mitochondrial dysfunction, and aging.
• 99% Purity: Manufactured to 99% purity, SS-31 (50mg) ensures the highest quality peptide for scientific research in mitochondrial health, cardiac protection, and oxidative stress reduction.
• Mitochondrial Protection: SS-31 is widely studied for its ability to reduce oxidative stress, stabilize mitochondrial function, and protect mitochondrial DNA, making it vital for research into age-related diseases, cellular energy, and heart disease.
• Cardioprotective and Neuroprotective: Studies show SS-31 has cardioprotective effects, reducing myocardial ischemia and improving cardiac output. It is also researched for its potential neuroprotective effects in diseases like Alzheimer’s, Parkinson’s, and Amyotrophic Lateral Sclerosis (ALS).

Common Research Applications:

• Mitochondrial Health and Energy Production: SS-31 (50mg) is used in mitochondrial health research, where it helps improve mitochondrial efficiency, restore cellular energy, and mitigate the harmful effects of oxidative stress. This peptide is key to studying cellular aging, metabolism, and energy production.
• Cardiovascular Protection and Heart Disease: SS-31 is extensively researched for its ability to protect the cardiac cells from oxidative damage and inflammation associated with heart failure, myocardial infarction, and ischemic heart disease. It helps reduce myocardial ischemia and cardiac remodeling in preclinical models of cardiovascular diseases.
• Oxidative Stress and Aging Research: This peptide plays a significant role in anti-aging studies, focusing on its ability to reduce free radical damage and slow the aging process at the cellular level by improving mitochondrial function. It is crucial in the study of age-related diseases such as neurodegenerative disorders, cognitive decline, and dementia.
• Neurodegenerative Disease Research: Researchers are investigating SS-31 for its potential to prevent and treat neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and ALS. The peptide is believed to reduce neuroinflammation, mitochondrial dysfunction, and oxidative damage to neurons and neuroglia.